View of TARGETED CANCER THERAPY VIA PURINERGIC RECEPTOR INHIBITION: THE USE OF P2X7 ANTAGONISTS

Return to Article Details TARGETED CANCER THERAPY VIA PURINERGIC RECEPTOR INHIBITION: THE USE OF P2X7 ANTAGONISTS Download Download PDF